Primary cells inBCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib
Author:
Affiliation:
1. Department of Clinical Genetics; Lund University; Lund Sweden
2. Department of Haematology; Linköping University Hospital; Linköping Sweden
3. Department of Medicine; Central Hospital Skövde; Skövde Sweden
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12957/fullpdf
Reference49 articles.
1. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016
2. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1;Macdonald;Acta Haematol,2002
3. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome;Li;Genes Chromosom Cancer,2012
4. A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm;Gervais;Leukemia,2013
5. LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome;Soler;Leukemia,2009
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort;Leukemia;2023-07-15
2. Synergetic effect of Azacitidine and Sorafenib in treatment of a case of myeloid neoplasm with sole chromosomal abnormality t(8;22)(p11.2;q11.2)/BCR-FGFR1 rearrangement;Cancer Genetics;2023-06
3. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement;Expert Review of Anticancer Therapy;2023-03-29
4. Research Progress of FGFR Small Molecule Inhibitors for Cholangiocarcinoma;Hans Journal of Medicinal Chemistry;2022
5. A case mimicking chronic myeloid leukemia with t(8;22)(p11;q11)/BCR-FGFR1 and sequential transformation to B-acute lymphoblastic leukemia and acute myeloid leukemia;Journal of Hematopathology;2021-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3